A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance
2021 · BMJ · 5,553 citations
https://doi.org/10.1136/bmj.n2061
J
Jane Blazeby
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
871
Papers
48.9K
Citations
98
h-index
419
i10-index
Jane Blazeby is an academic researcher from University Hospitals Bristol NHS Foundation Trust. The author has contributed to research in topics: Delphi Technique in Research & Health Systems, Economic Evaluations, Quality of Life & Esophageal Cancer Research and Treatment. The author has an h-index of 98, co-authored 741 publications.
ORCID: 0000-0002-3354-3330Papers by this author
worksThe COMET Handbook: version 1.0
2017 · Trials · 1,942 citations
https://doi.org/10.1186/s13063-017-1978-4
Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
2016 · PLoS Medicine · 635 citations
https://doi.org/10.1371/journal.pmed.1002148
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
2013 · The Lancet Oncology · 597 citations
https://doi.org/10.1016/s1470-2045(13)70549-7
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies
2017 · BMJ Open · 550 citations
https://doi.org/10.1136/bmjopen-2016-013537
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat